Fingerprint
Dive into the research topics of 'Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell carcinoma previously treated with tyrosine kinase inhibitors: A phase 2 consortium study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically